Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 49
|
ECE2017
|
Next issue
19th European Congress of Endocrinology
Lisbon,
Portugal
20 May 2017 - 23 May 2017
All volumes
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
20-23 May 2017, Lisbon, Portugal
Further information
Summary
Abstract Book
Programme
Volume Editors
Abstracts
Contents
19th European Congress of Endocrinology 2017
Prize Lectures and Biographical Notes
The European Journal of Endocrinology Prize Lecture
Hypothalmic AMPK: a golden target against obesity?
ea0049eje1
European Journal of Endocrinology Prize Winner
ea0049eje1biog
The Geoffrey Harris Prize Lecture
Toward hormone-based precision medicines for metabolic diseases
ea0049gh1
Geoffrey Harris Prize Winner
ea0049gh1biog
European Hormone Medal Lecture
Endocrine disruptors: Is it all Greek to us?
ea0049ehm1
European Hormone Medal Lecture
ea0049ehm1biog
Clinical Endocrinology Trust Lecture
Prospects for a new assessment of polycystic ovarian syndrome
ea0049cet1
Clinical Endocrinology Trust Lecture
ea0049cet1biog
IPSEN1
Redefining neuroendocrinology: stress, sex and cognitive and emotional regulation
ea0049ipsen1
Plenary Lectures
The fantastical world of hormones
The fantastical world of hormones
ea0049p1
The secret life of FGF21
The secret life of FGF21
ea0049p2
Update on regulation of steroidogenesis by aberrant hormone receptors
Update on regulation of steroidogenesis by aberrant hormone receptors
ea0049p3
The role of brain insulin resistance for the development of prediabetic phenotypes
The role of brain insulin resistance for the development of prediabetic phenotypes
ea0049p4
Browning of adipose tissue and metabolic regulation
Browning of adipose tissue and metabolic regulation
ea0049p5
Thyroid oncology in the crossroads of precision and narrative medicine
Thyroid oncology in the crossroads of precision and narrative medicine
ea0049p6
Symposia
Clinical Updates in Hypoparathyroidism
Congenital hypoparathyroidism
ea0049s1.1
Acquired hypoparathyroidism
ea0049s1.2
Clinical updates in hypoparathyroisism
ea0049s1.3
Evolving diagnostics in adrenal and neuroendocrine tumours
Role of genetic and biomarker tests for diagnosis of neuroendocrine tumours (NETs)
ea0049s2.1
Current status in morphological imaging in adrenal and gastrointestinal neuroendocrine tumours
ea0049s2.2
Current status in functional imaging
ea0049s2.3
From the pituitary to the periphery
Implication of the prolactin receptor in humans
ea0049s3.1
GHR: are there benefits of endocrine defects?
ea0049s3.2
Somatostatin receptors: news in the pituitary, lessons for the periphery
ea0049s3.3
2nd Joint Global Symposium on Obesity - The Many Dimensions of the Childhood Obesity Problem
Efficacy and effectiveness of physical activity and nutrition interventions in childhood obesity treatment
ea0049s4.1
The hunger genes: pathways to obesity
ea0049s4.2
Can we prevent childhood obesity?
ea0049s4.3
Turn your face to the sunshine
Effects of maternal thyroid function on infant neurodevelopment
ea0049s5.1
Vitamin D and rickets in African children
ea0049s5.2
Carbohydrate metabolism in patients with Cushing disease: a glance at the incretin system
ea0049s5.3
Treatment of hypothyroidism: what have we learned?
What is the clinical relevance of deiodinase polymorphisms?
ea0049s6.1
T4/T3 combination therapy: is there a true effect?
ea0049s6.2
Rebuilding your own thyroid from stem cells; the future therapy of hypothyroidism?
ea0049s6.3
Crosstalk between bone & other organ(ism)s
Immune system
ea0049s7.1
Osteocalcin signaling in myofibers is necessary and sufficient to increase exercise capacity
ea0049s7.2
Gut microbiota and bone metabolism
ea0049s7.3
Predictors of therapeutic response in functioning pituitary tumours
Molecular profiling
ea0049s8.1
MRI predictors of therapeutic response in GH-secreting pituitary tumours
ea0049s8.2
Predictors of therapeutic response in functioning pituitary tumours
ea0049s8.3
Novel type 2 diabetes treatment: Beyond glycaemic control
Experimental models
ea0049s9.1
Clinical studies on GLP1 - cardiovascular outcomes
ea0049s9.2
SGLT2 long term protective effects
ea0049s9.3
The Challenges of Male Fertility
Manipulating testicular androgen production to promote lifelong male health
ea0049s10.1
Fertility preservation in pre-pubertal and young males
ea0049s10.2
Pubertal induction and hormone replacement in young males
ea0049s10.3
New Roles for Nuclear Receptors
Identification of nuclear receptors network in male fertility
ea0049s11.1
Crosstalk between estrogen signalling and DNA damage repair
ea0049s11.2
The role of androgens in bone
ea0049s11.3
New development in Graves' Orbitopathy
The orbital fibroblast: a key player and target for therapy in graves' orbitopathy
ea0049s12.1
Management of Graves orbitopathy
ea0049s12.2
How to predict progression in Graves orbitopathy?
ea0049s12.3
Challenging pituitary diseases
Hypophysitis
ea0049s13.1
Empty sella
ea0049s13.2
Imaging of sellar masses
ea0049s13.3
Searching for the cause and approach in ectopic hormone syndromes
Rare Cushing's
ea0049s14.1
Searching for the cause and approach in ectopic hormone syndromes: rare acromegaly
ea0049s14.2
Rare hypoglycemia
ea0049s14.3
Metabolic surgery mechanisms to clinical results (Endorsed by the European Journal of Endocrinology)
The upper gut anti-incretin theory
ea0049s15.1
The role of bile in metabolic surgery
ea0049s15.2
Long term effects of metabolic surgery
ea0049s15.3
Late-breaking: the PCSK9 revolution
Beyond LDL lowering: the pleiotropic roles of PCSK9
ea0049s16.1
New strategies for inhibiting PCSK9
ea0049s16.2
PCSK9 inihibition in clinical practice: present and future
ea0049s16.3
What endocrinologists should know about the genomics of endocrine tumors
Clinical consequences of the recent genomics findings in thyroid cancer
ea0049s17.1
Clinical implications of SDHx mutations
ea0049s17.2
Will genomics help to finally classify NET's?
ea0049s17.3
Hyperandrogenism: challenges in clinical management
Hyperandrogenic states: pitfalls in diagnostic approach
ea0049s18.1
Metabolic perspectives for the non-classical CAH (NCAH)
ea0049s18.2
Hyperandrogenism and cardiometabolic risk
ea0049s18.3
How to incorporate the new guidelines for thyroid cancer in my clinical practice
Thyroid microcarcinoma: to treat or not to treat?
ea0049s19.1
When and how should we perform extensive surgery?
ea0049s19.2
Dynamic risk stratification in low-risk vs high-risk patients
ea0049s19.3
Beta cell replacement and plasticity (Endorsed by Endocrine Connections)
Stem cells for [beta] cell replacement in type 1 diabetes
ea0049s20.1
New Strategies for beta cell replacement
ea0049s20.2
Induction of pancreatic beta-like cell neogenesis
ea0049s20.3
Environmental influences on endocrine systems
Lifestyle and environmental factors in metabolic diseases; endocrine disruptors: new diabetogens?
ea0049s21.1
Evidence on reproductive disorders through endocrine disruption in-utero
ea0049s21.2
Euthyroid: towards a euthyroid Europe
ea0049s21.3
Rare bone diseases (Endorsed by the European Journal of Endocrinology)
Approach for clinicians
ea0049s22.1
Osteogenesis imperfecta & Ehlers-Danlos Syndrome
ea0049s22.2
Fibrous dysplasia of bone/McCune-Albright syndrome
ea0049s22.3
Endo Oncology: prolactin, GH and metabolic hormones in oncology pathogenesis (Endorsed by Endocrine Connections)
Prolactin regulation of prostate stem cells: potential implications in prostate cancer
ea0049s23.1
Is GH a cancer growth factor?
ea0049s23.2
Is reducing insulin-resistance relevant to prevent cancer?
ea0049s23.3
Obesity: Pharmacological solutions
MSH analogs
ea0049s24.1
The future drugs to come
ea0049s24.2
US experience update
ea0049s24.3
HPA axis regulation during a woman's life: impact on metabolic outcomes
HPA axis regulation during a woman's life: impact on metabolic outcomes
ea0049s25.1
HPA axis, insulin resistance and adipocytokines in the fetal-maternal unit
ea0049s25.2
11[beta]-hydroxysteroid dehydrogenase activity, androgen excess, and metabolic outcomes in woman
ea0049s25.3
Tissue specific defects in thyroid hormone action
Mouse models to study tissue specific hypothyroidism
ea0049s26.1
Syndromes of decreased sensitivity to thyroid hormone
ea0049s26.2
Restoring TH action in patients with transporter defects: the triac trial
ea0049s26.3
Vitamin D beyond bone (Endorsed by Endocrine Connections)
Heart & Vessels
ea0049s27.1
Fertility
ea0049s27.2
Muscles
ea0049s27.3
Sleep, love and reproduction (Endorsed by Endocrine Connections)
Candidate mechanisms underlying the association between poor sleep and obesity
ea0049s28.1
Oxytocin: from biology to love
ea0049s28.2
Kisspeptin and neurokinin B - novel reproductive hormones with therapeutic potential
ea0049s28.3
Novel predictors of diabetes
Novel predictors of type 1 diabetes
ea0049s29.1
Clinical and genetic indicators for diabetes prediction
ea0049s29.2
Novel predictors of diabetes - NAFLD, diabetes and CVD
ea0049s29.3
Moving away from old-fashioned steroidogenesis: what are the clinical implications?
Clinical relevance of alternative synthesis of androgens
ea0049s30.1
Clinical relevance of steroid precursors in adrenocortical tumors
ea0049s30.2
Glucocorticoid production in primary aldosteronism - from mechanisms to clinical implications
ea0049s30.3
Guided session 1
New international clinical practice guidelines for the care of girls and women with turner syndrome
ea0049gs1.1
Growth and puberty induction
ea0049gs1.2
Adult aspects of turner syndrome
ea0049gs1.3
Cardiovascular health issues in turner syndrome
ea0049gs1.4
Abstract unavailable
ea0049gs1.5
Abstract unavailable
ea0049gs1.6
Guided session 2
Aggressive pituitary tumours
ea0049gs2.1
Aggressive pituitary tumours
ea0049gs2.2
Aggressive pituitary tumours
ea0049gs2.3
Aggressive pituitary tumours
ea0049gs2.4
Aggressive pituitary tumours
ea0049gs2.5
Aggressive pituitary tumours
ea0049gs2.6
New Scientific Approaches
(1)
Identifying molecular signatures for cancer patient stratification via metabolomics and integrative bioinformatics
ea0049nsa1
Exosome profiling: potential in cancer diagnosis and stratification
ea0049nsa2
Genomic approaches on epigenetics
ea0049nsa3
CRISPR/cas9 cas9-generated mouse models of resistance to thyroid hormone due to THRA mutations
ea0049nsa4
Methodical tools for the structural elucidation of G-protein coupled receptors
ea0049nsa5.1
Small molecule agonists and antagonists as potential new therapeutics targeting the TSH receptor
ea0049nsa5.2
Mitochondrial epigenetics in obesity and its co-diseases
ea0049nsa6
DEBATES
Is there a role for medical therapy for non-functioning pituitary adenomas?
Is there a role for medical therapy for non- functioning pituitary adenomas? - FOR
ea0049d1.1
Is there a role for medical therapy for non- functioning pituitary adenomas? - AGAINST
ea0049d1.2
Incidentally discovered nonfunctioning pancreatic NETs: Surgery or not? (Endorsed by the European Journal of Endocrinology)
Incidentally discovered nonfunctioning pancreatic NETs: Surgery or not? - FOR
ea0049d2.1
Incidentally discovered nonfunctioning pancreatic NETs: Surgery or not? - AGAINST
ea0049d2.2
Drug holiday in osteoporosis (Endorsed by the European Journal of Endocrinology)
Drug holiday in osteoporosis - FOR
ea0049d3.1
Drug holiday in osteoporosis - AGAINST
ea0049d3.2
Is cardiovascular risk increased in women with PCOS?
Is cardiovascular risk increased in women with PCOS? - FOR
ea0049d4.1
Is cardiovascular risk increased in women with PCOS? - AGAINST
ea0049d4.2
Should we still ablate all patients undergoing total thyroidectomy for thyroid cancer?
Should we still ablate all patients undergoing total thyroidectomy for thyroid cancer? - FOR
ea0049d5.1
Should we still ablate all patients undergoing total thyroidectomy for thyroid cancer? - AGAINST
ea0049d5.2
Is it time for initial combination in type 2 diabetes?
Is it time for initial combination in type 2 diabetes? - FOR
ea0049d6.1
Is it time for initial combination in type 2 diabetes? - AGAINST
ea0049d6.2
Meet the Expert Sessions
(1)
How to manage diabetes in the elderly?
ea0049mte1
Diagnosis and management of GH deficiency - from childhood to adulthood
ea0049mte2
Hormone-secreting adrenal tumours in pregnancy
ea0049mte3
Treatment of congenital hypothyroidism
ea0049mte4
Modern spectrum of bone turnover markers - are they clinically useful?
ea0049mte5
How best to utilise technology in diabetes?
ea0049mte6
When and which treatment to use in Graves disease?
ea0049mte7
How best to manage neuroendocrine tumours? - Towards a new algorithm
ea0049mte8
Sarcopenia - why should we care?
ea0049mte9
Contraception in women with obesity, metabolic syndrome and diabetes
ea0049mte10
Drug induced osteoporosis
ea0049mte11
A modern approach for treatment PCOS
ea0049mte12
What can new insulins provide for management of diabetes?
ea0049mte13
Thyroid carcinoma: complicated cases
ea0049mte14
Gaucher disease: interdisciplinary management
ea0049mte15
New treatment approaches in dyslipidemia
ea0049mte16
A paediatric perspective of endocrine late complications following childhood cancer
ea0049mtne1
Providing nursing care for the adult patient with endocrine late effects of cancer treatment
ea0049mtne2
Unravelling the role of transient receptor potential channels in endocrine regulation and metabolism
ea0049mtbs1
Regulation and dysregulation of appetite and satiety
ea0049mtbs2
MicroRNAs and the regulation of glucose and lipid metabolism
ea0049mtbs3
Nurse Sessions
(1)
Clinical practice overlap and seamless care - diagnosis and management of hypothyroidism in patients with diabetes mellitus
ea0049n1.1
Clinical practice overlap and seamless care - links between hypogonadism, the metabolic syndrome and type 2 diabetes
ea0049n1.2
Clinical practice overlap and seamless care - challenges in the management of patients with Cushing's syndrome and diabetes
ea0049n1.3
Clinical practice overlap and seamless care - at risk of two endocrine emergencies: the patient with type 1 diabetes and Addison's disease
ea0049n1.4
Nurses professional development and networking session - obstructive sleep apnea and comorbidities in patients with pituitary adenomas
ea0049n2.1
Nurses professional development and networking session - utilising the competence framework to develop the role of endocrine nurses in adrenal insufficiency
ea0049n2.2
Nurses professional development and networking session - hybrid training of nurses in/for the endocrinology; train the trainer with help of e-learning modules
ea0049n2.3
Nurses professional development and networking session - developing a European position statement for endocrine nurses providing care for patients with adrenal insufficiency
ea0049n2.4
Update on diet and lifestyle throughout lifespan to improve health - prevalance and treatment of vitamin D deficieny in children
ea0049n3.1
Update on diet and lifestyle throughout lifespan to improve health - sexual hormones and bone, a close link throughout lifespan
ea0049n3.2
Update on diet and lifestyle throughout lifespan to improve health - osteoporosis and prevention of fractures: nurses can a play key role
ea0049n3.3
Oral Communications
Adrenal-Basic & Clinical
High resolution tissue mass spectrometry imaging: a new tool for identification of prognostic markers in adrenocortical carcinoma
ea0049oc1.1
EZH2: a master regulator of adrenal cortex homeostasis and zonation
ea0049oc1.2
Steroid metabolomics for accurate and rapid diagnosis of inborn steroidogenic disorders
ea0049oc1.3
The epidemiology of pheochromocytoma: increasing incidence and changing clinical presentation. A population-based retrospective study 1977-2015
ea0049oc1.4
Diagnostic accuracy of three confirmatory tests for primary aldosteronism: a prospective study and systematic review
ea0049oc1.5
Diabetes Prediction and Complications
microRNA expression profile in plasma from patients with type 1 diabetes: a case-control study and bioinformatics analysis
ea0049oc2.1
Effectiveness of complex therapy in patients with comorbidity of type 2 diabetes and essential hypertension depending on genetic polymorphism PPAR[gamma]2
ea0049oc2.2
GLP-1 based multi-agonists-induced signaling includes profound TRP channel involvement in insulin secretion
ea0049oc2.3
Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial
ea0049oc2.4
Urinary peptidomics for the detection of diabetic kidney disease
ea0049oc2.5
Receptors & Signalling
Epigenetic regulation of aldosterone synthase gene, CYP11B2 by potassium
ea0049oc3.1
Elucidating the role of Liver X receptors (LXRs) in the testis using lipid systems biology
ea0049oc3.2
AKR1C3-mediated adipose androgen generation drives lipotoxicity in polycystic ovary syndrome
ea0049oc3.3
Treatment with thyroid hormone metabolite 3,5-T2 alters cholesterol and sex steroid metabolism in mouse liver
ea0049oc3.4
Accurate staging of non-alcoholic fatty liver disease through analysis of the urinary steroid metabolome
ea0049oc3.5
Thyroid Disease 1
Hypothyroidism in pregnancy is associated with twin pregnancies and with adverse obstetric outcome: Analysis of 142,277 deliveries data from a single center
ea0049oc4.1
Inducible thyrocyte-specific Gs alpha-deficient mice as a novel model for hypothyroidism
ea0049oc4.2
A novel variant in the SERPINA7 gene causing partial TBG deficiency in a women and two male siblings: molecular and protein structural analysis
ea0049oc4.3
The TSH receptor reaches the trans-Golgi network to induce PKA activation and trigger gene transcription
ea0049oc4.4
Levothyroxine replacement therapy: once treatment is started, should it last indefinitely?
ea0049oc4.5
Cardiovascular Endocrinology
Polarized epithelial cells release exosomes loaded with miRNAs capable of interacting with HSD11B2 and MR genes
ea0049oc5.1
Association of PPAR gamma gene expression with dietary intake of fat and oil among non-diabetic subjects
ea0049oc5.2
Cardio metabolic assessment of lamin A/C mutation carriers according to R482 or Non-R482 mutation
ea0049oc5.3
Food history characterization of Portuguese centenarians, nutritional biomarkers and cardiovascular risk: case control study
ea0049oc5.4
Sex dimorphism of renal corticosteroid signaling during development and long term consequence on blood pressure
ea0049oc5.5
Diabetes therapy and complications
A passe-PAR2 for [beta]-cell regeneration and protection
ea0049oc6.1
Insulin-mimetic effects of short-term Rapamycin in type 1 diabetic patients prior islet transplantation
ea0049oc6.2
Alterations in DNA methylation from peripheral blood cells in humans threated with metformin
ea0049oc6.3
Copeptin and its association to cardiovascular dysfunction in type 2 diabetes
ea0049oc6.4
Activation of the Renin-Angiotensin II-Aldosterone-System leads to increases in extracellular protein disulfide isomerase: role in insulin resistance
ea0049oc6.5
Cardiovascular endocrinology (1)
Estrogens enhance gonadectomy-induced adrenocortical tumor progression in mice
ea0049oc7.1
Targeted molecular markers derived from genomic classification for adrenocortical cancer prognostication
ea0049oc7.2
High Total 68Ga-DOTATATE-Avid Tumor Volume (TV) is associated with low progression-free survival and high disease-specific mortality rate in patients with neuroendocrine tumors
ea0049oc7.3
A novel insight into the anticancer mechanism of metformin in Pancreatic Neuroendocrine Tumor cells
ea0049oc7.4
Regulation of steroid receptor signalling by tumor suppressor INPP4B
ea0049oc7.5
Neuroendocrinology
Elucidating the molecular mechanisms underlying AIP dependent tumorigenesis
ea0049oc8.1
Knocking down/out the prokineticin pathway during zebrafish development results in the GnRH neurons axons misguiding
ea0049oc8.2
RNA sequencing and RT-qPCR identify different gene expression profiles in fast- vs. slow-growing non-functioning pituitary adenomas
ea0049oc8.3
Cerebrovascular stroke incidence in GH-treated adults: experience from KIMS (Pfizer International Metabolic Database)
ea0049oc8.4
Ephrin-B2 is required for pituitary development
ea0049oc8.5
Thyroid Disease 2
Thyroid function and metabolic syndrome: results from the population-based LifeLines Cohort study
ea0049oc9.1
Effect of restoration of euthyroidism in patients with hypothyroidism on cold induced thermogenesis
ea0049oc9.2
How much of the genetic predisposition to Hashimoto's thyroiditis can be explained by genes commonly associated with the disease?
ea0049oc9.3
Thyroid dysfunction during the use of PD-1/PD-L1 blockade predicts its therapeutic response in the patients with advanced non-small cell lung cancer
ea0049oc9.4
Selenium supplementation in the management of thyroid autoimmunity during pregnancy: results of the 'Serena Study' a randomized, double-blind, placebo-controlled trial
ea0049oc9.5
Bone & Calcium Homeostasis
Treatment of 711 patients with hypoparathyroidism: a retrospective study in 3 German endocrine centres
ea0049oc10.1
Evaluation of bone quality, measured by trabecular bone score (TBS) in patients with primary hyperparathyroidism (PHH) with and without surgery
ea0049oc10.2
High prevalence of radiological vertebral fractures in patients with differentiated thyroid carcinoma undergoing L-thyroxine TSH-suppressive therapy
ea0049oc10.3
The effect of denosumab or bisphosphonates in women with severe postmenopausal osteoporosis after completion of teriparatide treatment
ea0049oc10.4
G[alpha]11-Phe220Ser loss-of-function mutation causes familial hypocalciuric hypercalcemia type-2 (FHH2) by disrupting a hydrophobic cluster critical for G-protein signaling
ea0049oc10.5
Obesity
Role of Extracellular vesicles in the crosstalk between adipocytes and pancreatic beta-cells
ea0049oc11.1
Three year prospective study in morbidly obese patients between longitudinal gastrectomy and gastric bypass based on a composite outcome combining weight loss efficacy and surgery related complications (PHRC SLEEVE K060213 / IDRCB2007-A00373-50)
ea0049oc11.2
Interleukin-1 antagonism decreases cortisol levels in obese individuals
ea0049oc11.3
Comparing effects of weight loss by liraglutide with intensive lifestyle modification on hepatic steatosis, inflammation and stiffness, and insulin resistance in obese Asians with non-alcoholic fatty liver disease (NAFLD)
ea0049oc11.4
Differentiating constitutional thinness from anorexia nervosa in DSM 5 era
ea0049oc11.5
Pituitary Clinical
T2-Weighted signal intensity of functional pituitary adenomas: correlation with clinicopathological findings and response to treatment
ea0049oc12.1
Use of temozolomide in a large cohort of patients with aggressive pituitary tumours and pituitary carcinomas: Results from a European Society of Endocrinology (ESE) survey
ea0049oc12.2
Recombinant Growth Hormone added to physical therapy in GH-deficient adults with complete (ASIA A) Spine Injury (EudraCT 2011-005377-23)
ea0049oc12.3
Subclinical cardiovascular system dysfunction in the patients with Cushing's disease
ea0049oc12.4
Effects of pegvisomant and somatostatin receptor ligands on risk of vertebral fractures in patients with Acromegaly
ea0049oc12.5
Reproduction & Endocrine Disruption
Abstract unavailable
ea0049oc13.1
Thyroid peroxidase antibodies do not predict outcome in 900 women with recurrent pregnancy loss
ea0049oc13.2
Sertoli cell expressed hydroxysteroid (17beta) dehydrogenase 1 is required for male fertility
ea0049oc13.3
Diabetes mellitus: a new cause of male infertility
ea0049oc13.4
Urinary cadmium excretion is associated with increased synthesis of cortico- and sex steroids in a family-based Swiss population study
ea0049oc13.5
Thyroid Cancer
Anti-Mullerian hormone (AMH) in pre-menopausal females after ablative radioiodine (RAI) treatment for differentiated thyroid cancer (DTC): single-center study
ea0049oc14.1
Suppression of heme oxygenase-1 inhibits growth and invasion of thyroid cancer
ea0049oc14.2
TERT, BRAF and NRAS in the molecular profile of metastatic thyroid cancer: differences between primary and distant disease
ea0049oc14.3
Inverse relation between thyroid cancer incidence and threshold for thyroid surgery: a national population-based retrospective study
ea0049oc14.4
Dose aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classical papillary carcinoma?
ea0049oc14.5
Guided Posters
Adrenal 1
PRKACA mutations in adrenal Cushing can alter substrate specificity
ea0049gp1
Contribution of retinoic acid receptor signalling to adrenal cortex morphology and functional zonation through modulation of WNT/[beta]-catenin pathway
ea0049gp2
Exosomal hsa-miR-483-5p and hsa-miR-101 are potential minimally invasive biomarkers of adrenocortical carcinoma
ea0049gp3
Androgen receptor signalling is essential for regression of the adrenal x-zone and regulation of the adrenal cortex in the male mouse
ea0049gp4
Protein Kinase A signaling saves regulatory subunit II[beta] from PRKACA mutation-mediated degradation
ea0049gp5
Involvement of ARMC5 in proliferation and cell cycle control of human cell cultures from adrenal nodules of primary macronodular adrenocortical hyperplasia (PMAH)
ea0049gp6
Identification of a new glucocorticoid receptor mutation underscores the substantial prevalence of genetic NR3C1 alterations in adrenal hyperplasia: the French National Research Program MUTA-GR
ea0049gp7
Clinical and translational relevance of circulating miR483 in adrenocortical cancer
ea0049gp8
Mortality is increased in patients with Cushing's disease in long-term remission: A nation-wide study
ea0049gp9
Expression of GATA transcription factors and their role in the aetiology of Testicular Adrenal Rest Tumours
ea0049gp10
Adrenal 2
A country comparison of glucocorticoid replacement therapy in patients with primary and secondary adrenal insufficiency: data from the EU-AIR
ea0049gp11
Activation of the cAMP/PKA transduction system triggers abnormal expression of the serotonin signaling pathway in human adrenocortical cells
ea0049gp12
PRKARIA (Carney complex gene) is a major regulator of the tight link between cell cycle phases and steroidogenesis in the adrenocortical tumor cells H295R
ea0049gp13
Simultaneous assays of aldosterone and renin concentrations in just ten minutes could change the clinical assessment for the diagnosis of primary aldosteronism
ea0049gp14
Integrated genomic and phenomic analysis reveals key molecular pathways of aldosterone producing adenoma
ea0049gp15
Cardiovascular features of autonomous cortisol secretion in patients with adrenal incidentalomas
ea0049gp16
Hypercortisolism is prevalent in newly diagnosed type 2 diabetes: a prospective study of 384 consecutive patients
ea0049gp17
Effects of two mineralocorticoid receptor antagonists on the morphology of the adrenal cortex
ea0049gp18
Plasma cortisol and aldosterone responses to insulin tolerance test and sodium depletion in women with non classic 21-hydroxylase deficiency caused by bi-allelic CYP21A2 mutations (NC-CAH)
ea0049gp19
Which are the factors and causes of death in patients with adrenal insufficiency? Mortality data from EU-AIR
ea0049gp20
Adrenal 3
Is diabetes mellitus associated with catecholamine-secreting tumours always a secondary diabetes?
ea0049gp21
Epithelial to mesenchymal transition in adrenocortical tumours: focus on FGF-FGFR pathway and c-MET
ea0049gp22
Clinical features and treatment outcomes in a group of SDHx-related pheochromocytoma/paraganglioma patients
ea0049gp23
Increased exosomes in endogeneous Cushing syndrome
ea0049gp24
Tumor microenvironment increases migration/invasion of murine pheochromocytoma SDHB silenced spheroids
ea0049gp25
Metformin reduces viability and proliferation of pheochromocytoma cells in vitro
ea0049gp26
The role of in vivo metabolomics using H-MRS in SDH deficient disease
ea0049gp27
A PRKACB somatic mutation in a cortisol producing adenoma: a new example of protein kinase A activation leading to adrenal Cushing syndrome
ea0049gp28
Familial case of SDHB mutation presenting as a macroprolactinoma
ea0049gp29
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with cyclical ectopic adrenocorticotrophic hormone secretion
ea0049gp30
Long-term treatment of acute ectopic ACTH syndrome with Etomidate
ea0049gp31
Multiple pathologic fractures as the presenting manifestation of Cushing's syndrome in patients with vitamin D receptor FokI gene polymorphism
ea0049gp32
Bone & Calcium Homeostasis 1
[ldquo]Hyperparanet[rdquo]: a multicenter Italian study on Primary Hyperparathyroidism
ea0049gp33
Fat mass distribution and resistin are independent predictors of bone mass in postmenopausal, but not premenopausal women.
ea0049gp34
Aldosterone and parathyroid hormone - is there a connection?
ea0049gp35
Relationship between circulating microRNAs and bone mineral density in patients with active acromegaly
ea0049gp36
Effects of BCR-ABL targeted tyrosine kinase inhibitors on the whole transcriptome pattern of cultured murine osteoblasts
ea0049gp37
Decreased trabecular bone score but not bone mineral density in patients with acromegaly and concurrent hypogonadism: cross-sectional study with healthy controls
ea0049gp38
Association of changes in serum urate level and bone mineral density during treatment with teriparatide: a retrospective observational study
ea0049gp39
Coexistence of primary hyperparathyroidism with papillary thyroid carcinoma: a case series
ea0049gp40
Follow-up of patients with surgical hypoparathyroidism: unknown cause of renal function decline?
ea0049gp41
Expression of hypoxia-inducible factor-1[alpha] in Calbindin-D9k Knockout mice
ea0049gp42
Bone & Calcium Homeostasis 2
Chromosome 2q37 microdeletions in two cases of sporadic PHP-1B with broad GNAS imprinting defects
ea0049gp43
Investigation of total and free 25OHD vitamin levels in patients with chronic renal failure on different dose of cholecalciferol
ea0049gp44
Methylation patterns at the novel DMR of GNAS (GNAS-AS2) in pseudohypoparathyroidism 1B (PHP1B or iPPSD3) subtypes
ea0049gp45
Vitamin D correction elevates apolipoprotein levels in a sex-specific manner
ea0049gp46
Recombinant human parathyroid hormone (rhPTH[1-84], parathyroid hormone rDNA) improves hypercalciuria in patients with hypoparathyroidism: 3-year analysis from RACE study
ea0049gp47
Vitamin D levels after 4 weeks of very low calorie diet (VLCD)
ea0049gp48
Upper gastrointestinal symptoms, endoscopic and pathological features, and serum gastrin and chromogranin A levels in patients with primary hyperparathyroidism
ea0049gp49
Localisation of parathyroid adenomas using 11C-methionine-PET/CT when conventional imaging methods are negative
ea0049gp50
Calcium to phosphorous ratio (Ca/P) as helpful index to recognize primary hyperparathyroidism, but not primary hypoparathyroidism: a big-data approach
ea0049gp51
Cardiovascular & Lipid Endocrinology
Liraglutide prevents right ventricle hypertrophy by avoiding ACE1 & ACE2 reduction in an experimental model of idiopathic pulmonary fibrosis
ea0049gp52
Clinical, laboratory and cardiac parameters in overt primary hypothyroidism versus overt central hypothyroidism
ea0049gp53
Correlation between triglyceride glucose index (TyG) and coronary artery calcification in Korean adults
ea0049gp54
Both oral and vaginal combined hormonal contraceptives induce unbeneficial metabolic effects in women with PCOS: a randomized study
ea0049gp55
PCSK9 in relation to coronary damage severity in patients with cardiovascular disease
ea0049gp56
Clinical significance and hormonal relationships of visceral adiposity index (VAI) in independently living old subjects
ea0049gp57
Circulating levels of miR24-1 cluster microRNAs are increased in primary aldosteronism
ea0049gp58
Body composition and testosterone determined VO2max in 780 young men - results from the Odense Androgen Study
ea0049gp59
Probiotics and nutraceuticals as a new frontier in obesity prevention and management
ea0049gp60
Constructing a long-acting leptin analogue
ea0049gp61
Developmental & Protein Endocrinology
Effects of prenatal dexamethasone on fetal rat ovary
ea0049gp62
Does the loss of RAD52 in PC contribute to resistance to antiandrogen therapy?
ea0049gp63
Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover
ea0049gp64
3-year safety and efficacy Update of the VERTICAL & VISTA trials of somavaratan (VRS-317), a long-acting rhGH, in children with Growth Hormone Deficiency (GHD)
ea0049gp65
Achievement of a suitable basis of comparison in phase 2 and 3 clinical trials (VERTICAL/VISTA, and VELOCITY) comparing somavaratan vs daily rhGH for pediatric GH deficiency
ea0049gp66
Karyotype and mid-childhood gonadotropin concentrations in prediction of spontaneous puberty in Turner syndrome patients
ea0049gp67
Assessment of reports of behaviour by patients and their parents in paediatric Cushing disease
ea0049gp68
5[beta]-reductase (AKR1D1) is a potent regulator of carbohydrate and lipid metabolism and inflammation in human liver
ea0049gp69
The adverse effects of prescribed glucocorticoids are worsened by co-administration of 5[alpha]-reductase inhibitors
ea0049gp70
Diabetes & complications 1
Carbohydrates metabolism and H. pylori: case-control study
ea0049gp71
Specific plasma amino acids alternations associated with metabolic syndrome
ea0049gp72
Permanent neonatal diabetes in a 24 year old Spanish patient
ea0049gp73
Rescue study of trapped AVPR2 mutants with chemicals
ea0049gp74
GLP-1 acutely regulates carbohydrate and lipid metabolic routes in the liver
ea0049gp75
Increased risk of diabetes and hyperglycaemia associated with treatment with statins, beta-blockers and diuretics: the PPP-Botnia study
ea0049gp76
Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection
ea0049gp77
Contribution of genetic predisposition and lifestyle to gestational diabetes risk
ea0049gp78
The rs2292239 polymorphism in the ERBB3 gene is associated with risk for type 1 diabetes mellitus
ea0049gp79
Trace elements as an oxidative stress marker in women with gestational diabetes and their neonates
ea0049gp80
Abstract unavailable
ea0049gp81
Reduced level of soluble TLR2 in type 2 diabetes despite increased TLR2 monocyte expression
ea0049gp82
Diabetes & complications 2
Vitamin D metabolites and IL1[beta] RS16944 polymorphism in type 2 diabetes patients: evidence for functional interaction
ea0049gp83
Antidiabetic medication use and the risk of fracture in type 2 diabetic patients: a nested case-control study
ea0049gp84
Abstract unavailable
ea0049gp85
Increased incidence of diabetes mellitus 30 years after the radiation impact in persons exposed to ionizing radiation during the Chernobyl NPP accident
ea0049gp86
Baicalin lowers glucose intolerance by controlling pancreatic hormone in high fat-induced obese diabetic rats
ea0049gp87
Effect of insulin on neurotrophins' levels in the muscular wall of mice intestine and colon
ea0049gp88
Clinical assessment of trabecular bone microstructure in type 2 diabetes mellitus with Trabecular Bone Score (TBS)
ea0049gp89
The G allele of the BDKRB1 rs12050217 polymorphism is associated with protection for diabetic retinopathy
ea0049gp90
Dipeptidyl peptidase-4 inhibitor therapy and risk of diabetic retinopathy: a population based study
ea0049gp91
Non-genetic rat model of nephropathy in type 2 diabetes with attenuated streptozotocin-induced tubular alteration
ea0049gp92
Diabetes therapy & complications 1
microRNA expression profile in plasma from patients with diabetic kidney disease
ea0049gp93
The A allele of the -866G/A polymorphism in UCP2 gene decreases high glucose-induced UCP2 expression in HUVECs
ea0049gp94
The relation between PON-1 activity and 25-OH hydroxyvitamin D3 levels and other biochemical parameters in diabetic patients with respect to obesity and diabetic complications
ea0049gp95
High prevalence of lower extremity peripheral artery disease in type 2 diabetes patients with diabetic nephropathy and the role of netrin-1 levels
ea0049gp96
Comparison of current perception threshold measured by Neurometer in patients with type 2 diabetes mellitus to a group of normal individuals
ea0049gp97
Gestacional diabetes mellitus: the new screening criteria and its outcomes
ea0049gp98
Higher levels of adiponectin might contribute to lower bone mass observed in patients with type 1 diabetes, through alterations in osteocalcin energy circuit signaling of bone cells.
ea0049gp99
Type 1 diabetes and hearing loss: a meta-analysis
ea0049gp100
Abstract unavailable
ea0049gp101
Comparison of the effects of combinations of different antihypertensive therapies on microalbuminuria and renal functions in type 2 diabetic patients
ea0049gp102
Diabetes therapy & complications 2
Abstract unavailable
ea0049gp103
Non-stimulated c-peptide is independently associated with requirement at 1 year for insulin therapy in patients with diabetes: a retrospective cohort study of 872 patients
ea0049gp104
Ceramide synthase 6 inhibition as a novel therapeutic approach for obesity and type 2 diabetes
ea0049gp105
Outcomes of integrating personal continuous glucose monitors with insulin pumps in a University Diabetes Unit
ea0049gp106
Specific Oct1 gene variants are associated with changes in the risk of cardiovascular death in metformin users
ea0049gp107
Liraglutide improves carotid intima-media thickness in pre-elderly and elderly patients with type-2 diabetes: an 18-month prospective, real life study
ea0049gp108
Treatment of diabetic ketoacidosis at type 1 diabetes mellitus presentation: 13 year experience from a tertiary centre (2004-2016)
ea0049gp109
The method of reporting hypoglycemia in Randomized Control Trials (RCTs): a systematic review on RCTs conducted for SGLT-2 inhibitors
ea0049gp110
Hepatic effects of GLP-1 receptor agonist Liraglutide in patients with type 2 diabetes
ea0049gp111
Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes Mellitus
ea0049gp112
Endocrine Nursing
Impact of the socio-economic level on the management in type 2 diabetes
ea0049gp113
Outcomes of a nurse-led thyroid clinic at a tertiary-care endocrine centre
ea0049gp114
Education, patient empowerment and admission avoidance
ea0049gp115
Recovery of the hypothalamus-pituitary-adrenal axis after transsphenoidal surgery for pituitary adenomas
ea0049gp116
The Swedish Pituitary Register Nursing Group (SPRNG) Projects and Experiences
ea0049gp117
Endocrine Tumours
Luteinizing hormone receptor mediated GATA4 induction promotes adrenocortical tumorigenesis in gonadectomized mice
ea0049gp118
Targeted molecular analysis in adrenocortical carcinomas: a way towards personalized medicine
ea0049gp119
Evaluation of the occurrence of the manifestations of Carney complex in a french cohort of 70 patients during a three years standardized follow-up
ea0049gp120
Immunity in adrenocortical carcinoma patients - interplay between anti-cancer immunity and steroid hormones
ea0049gp121
The natural history of adrenal incidentaloma - results from the international prospective multi-centre EURINE-ACT study
ea0049gp122
Outcome of patients with adrenocortical cancer after discontinuation of adjuvant mitotane therapy
ea0049gp123
VHL
Genotype and risk stratification of pancreatic neuroendocrine tumors in patients with von hippel-lindau disease
ea0049gp124
GPER-stimulation increases proliferation in colorectal cancer via the Hippo signalling pathway
ea0049gp125
Inhibition of hRAS and CDK4/6 leads to an antiproliferative activity, blocks cell cycle and induces cell death in anaplastic thyroid cancer cell lines
ea0049gp126
Benign prostatic hyperplasia is associatied with liver inflammation: it's time for prevention?
ea0049gp127
Peptides derived from the sst5TMD4 extracellular domain increase malignancy of endocrine-related cancer cells
ea0049gp128
Androgen receptor activation inhibits endothelial cell proliferation through an extra-nuclear signaling pathway
ea0049gp129
Long non-coding RNA expression profiles in human parathyroid tumors
ea0049gp130
Female Reproduction
Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial
ea0049gp131
Testosterone administration decreases insulin sensitivity (IS) in adult female sheep born to testosterone treated mothers
ea0049gp132
Influence of BMI on AMH levels in non-PCOS women
ea0049gp133
Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis (EM)-associated pain: Phase 2 safety and efficacy 24-week results
ea0049gp134
Brown adipose tissue thermogenesis in women with polycystic ovary syndrome
ea0049gp135
Dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin improved beta cell function and prevented a conversion rate to MTG and DM2 in metformin intolerant PCOS with high metabolic risk
ea0049gp136
Genetic susceptibility for adrenal hyperandrogenism in polycystic ovary syndrome
ea0049gp137
Turner's syndrome and abnormal liver chemistry: relationship with karyotype in a large dedicated clinic
ea0049gp138
Sensitivity of hypothalamo-pituitary-adrenal axis in women with PCOS
ea0049gp139
Nonalcoholic fatty liver disease liver fat score (NAFLD-LFS) could be used for the assessment of NAFLD in women with PCOS
ea0049gp140
Effects of central sympathoinhibition with moxonidine on the elevated sympathetic nervous activity and downstream metabolic abnormalities observed in polycystic ovary syndrome
ea0049gp141
Steroid receptors involvement in enamel hypomineralization resulting from exposure to low-dose DEHP and bisphenol A
ea0049gp142
Male Reproduction and Endocrine Disruptors
In vitro
effects of Bisphenol A on two metabolic receptors signaling: MC4R and FFAR1
ea0049gp143
Altered protein expression of cell cycle- and EMT-associated genes by bisphenol compounds in MCF-7 CV human breast cancer cells via estrogen receptor dependent pathway
ea0049gp144
Reproductive toxicity of low dose nonylphenol in mice: a two-generation study
ea0049gp145
Psychological rather than organic and/or relational components are involved in sexual dysfunction in Young/Middle aged human immunodeficiency virus (HIV)-Infected Men
ea0049gp146
Effects of physical exercise or metformin on testosterone deficiency and erectile dysfunction associated to metabolic syndrome
ea0049gp147
Impacts of a single ablative dose of radio iodine therapy for differentiated thyroid carcinoma on testicular function: results from the SAPIRA study
ea0049gp148
Presentation, clinical features and long-term follow-up of Leydig cell tumours of the testis: 77 cases from a single center experience
ea0049gp149
Semen quality in patients with adult-onset hypogonadotropic hypogonadism
ea0049gp150
Neuroendocrinology & Growth Hormones
Growth hormone-releasing hormone (GHRH) antagonists, MIA-602 and MIA-690, inhibit survival and proliferation of human pleural mesothelioma cells
ea0049gp151
Somapacitan expected to provide IGF-I levels suitable for once-weekly dosing in children
ea0049gp152
Evaluating CHARGE syndrome in CHD7-positive CHH patients: clinical implications
ea0049gp153
The effect of chronic hypothalamic-pituitary-adrenal axis activation on hypothalamic glucagon-like peptide-1 action in an animal model of depression and
in vitro
studies
ea0049gp154
A novel purified polyclonal antibody towards T-Pit is a reliable marker of corticotroph cell differentiation
ea0049gp155
Liraglutide treatment prevented the increased expression of proinflammatory cytokines in the hippocampus of male pups in a perinatal stress model of food restriction
ea0049gp156
Predictors of permanent, transient and three-phase postoperative diabetes insipidus
ea0049gp157
The effect of chronic tianeptine administration on NLRP3 inflammasome pathway - study in an animal model of depression
ea0049gp158
Pituitary androgen receptor signalling is a novel negative regulator of prolactin production
ea0049gp159
Somatic mutations in USP8 are frequent events in pituitary tumors causing Nelson's syndrome
ea0049gp160
Obesity
The association between olfaction and taste functions with serum ghrelin and leptin levels in obese women
ea0049gp161
Sarcopenic obesity and associated factors in older adults with diabetes: the 2009-2010 Korean National Health and Nutrition Examination Survey
ea0049gp162
Resistance training reduces skeletal muscle inflammation even after 4-week detraining in obese rats
ea0049gp163
miR-26b is decreased in obesity and is associated with insulin resistance and visfatin levels
ea0049gp164
The effect of FTO polymorphism rs 9939609 on obesity and metabolic disturbances in Polish people from Lower Silesia
ea0049gp165
Role of Elovl6 in brown and beige adipose tissue during [beta]3-adrenergic receptor activation
ea0049gp166
A link between sex hormones, obesity and gut microbiota
ea0049gp167
Effects of short sleep duration on energy metabolism and energy balance in subjects with overweight and obesity
ea0049gp168
Blood mercury concentration in relation to overweight or obese among Korean children and adolescents: KNHANES 2009-2013
ea0049gp169
Association of the FTO gene rs9939609 polymorphism with obesity in the Republic of Tatarstan
ea0049gp170
Effect of bariatric surgery on sexual function and sex hormone levels in obese patients: a meta-analysis
ea0049gp171
Lipolytic effects of endogenous 3-iodothyronamine (T1AM) and synthetic analog SG-2 in vivo and in cultured adipocytes
ea0049gp172
Pituitary
A comparison of single-dose effects of short acting somatostatin analogs: octreotide vs pasireotide in patients with active acromegaly after surgical debulking
ea0049gp173
Efficacy and safety of switching to pasireotide LAR alone or in combination with pegvisomant in acromegaly patients controlled with combination treatment of first-generation somatostatin analogues and weekly pegvisomant (PAPE study): a prospective open-label 48 week study, preliminary results 24 weeks
ea0049gp174
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients
ea0049gp175
Minimally Invasive Diagnosis and Direct Transnasal Surgery: a single centre series of 100 children with Cushing's Disease with long term follow-up
ea0049gp176
Octreotide subcutaneous (s.c.) depot, a novel ready-to-use formulation, provides higher exposure and maintains response in patients with acromegaly and functioning neuroendocrine tumours (NETs) previously treated with long-acting octreotide: Results from a phase 2, open-label, multicentre, randomized study
ea0049gp177
Sleep patterns in patients with non-functional GHRH receptor
ea0049gp178
Correction of sustained hyponatremia secondary to SIAD by the use of chronic tolvaptan therapy is associated with a reduction in Emergency Room visits, hospital admissions and days of hospitalization over a 3-year period
ea0049gp179
Outcome of non-functioning pituitary adenomas that regrow after primary treatment: a study from two large specialist UK centers
ea0049gp180
Targeting either GH or IGF-I levels during somatostatin analogue treatment in patients with acromegaly: A randomized, investigator-initiated multicenter study
ea0049gp181
Brain white matter damage and volumes of hippocampus and hypothalamus correlates to cognitive function in craniopharyngioma
ea0049gp182
Copeptin - a sensitive marker of an altered CRH-axis in pituitary disease
ea0049gp183
Hormonal and metabolic effects of long-term cabergoline withdrawal in patients with hyperprolactinemia
ea0049gp184
Pituitary & endocrine Tumours
Localization of benign insulinomas using glucagon-like peptide-1 receptor (GLP1-R) SPECT/CT and PET/CT and MRI in a prospective clinical study
ea0049gp185
24 hour urinary 5-hydroxyindoleacetic acid (5-HIAA) doubling-time (DT) is associated with disease-specific mortality (DSM) and progression-free survival (PFS) in patients with neuroendocrine tumors (NETs)
ea0049gp186
Pasireotide alone or in combination with cabergoline effectively controls urinary free cortisol levels: results from a prospective study in patients with Cushing's disease (CAPACITY)
ea0049gp187
Vertebral fractures are prevalent among patients with acromegaly in spite of normal bone mineral density reflecting overall duration of disease regardless of biochemical control or cure
ea0049gp188
Evaluation of pituitary toxicity after radiotherapy for cerebral chondrosarcomas in adult patients
ea0049gp189
Safety of long-term growth hormone (GH) treatment in adults with GH deficiency (GHD): an analysis from the NordiNet® International Outcome Study
ea0049gp190
GH and IGF-1 levels at 12 weeks predict long-term responses to lanreotide Autogel in treatment-naive acromegalic patients: post-hoc analyses from the PRIMARYS study
ea0049gp191
Long-term treatment with pegvisomant (Somavert®): Observations from 2090 acromegaly patients followed in ACROSTUDY
ea0049gp192
Amenorrhea without vasomotor symptoms in women over 40: A sign of pathological hyperprolactinemia?
ea0049gp193
Serotonin, ATRX and DAXX as differential diagnostic markers of neuroendocrine tumours (NETs) in the sellar region. An immunohistochemical study in a large series of pituitary adenomas and in a non-pituitary NET
ea0049gp194
Long-term follow-up of a family with a large AIP gene deletion: variable phenotypes and challenges in the management
ea0049gp195
Diagnosis of acromegaly: Sex and BMI are the major determinants of growth hormone suppression during oral glucose tolerance test (OGTT)
ea0049gp196
Thyroid 1
Cognitive functions in primary hypothyroidism on selenium supplementation
ea0049gp197
Which is the best tool to use when initiating the differential diagnosis of a thyrotoxic patient? A challenge to current guideline recommendations
ea0049gp198
Cardiovascular risk factors in patients with autoimmune thyroiditis
ea0049gp199
Evaluation of the effectiveness of personalized radioiodine treatment in Graves' disease
ea0049gp200
Abstract unavailable
ea0049gp201
Citrus flavanones naringenin and hesperetin induced mild functional alteration in thyroids of old-aged Wistar rats
ea0049gp202
The oxford multidisciplinary thyroid eye disease (TED) clinic; can short waiting times and use of steroid sparing agents (SSA) reduce total steroid dose and requirement for surgery/radiotherapy?
ea0049gp203
24-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules
ea0049gp204
Association of vitamin D levels with thyroid function and autoimmunity
ea0049gp205
Thyroid 2
Early use of steroid-sparing agents in treatment of moderate-to-severely active thyroid eye disease
ea0049gp206
Prediction of response to methimazole based on clinical symptoms in new onset graves' patients, using neural networks
ea0049gp207
Serum Interleukin-37 (IL-37) levels were increased and correlated with oxidative stress parameters in Hashimoto's Thyroiditis (HT) patients
ea0049gp208
The increased immunohistochemical expression of IL-23 in Hashimoto's thyroiditis but not in Graves' disease patients
ea0049gp209
Laser ablation of benign thyroid nodules without anesthesia: clinical tolerance, hazards and complications
ea0049gp210
Orbital ectopic thyroid mistaken for mestastases
ea0049gp211
Association of the Period3 clock gene polymorphism with autoimmune thyroid diseases
ea0049gp212
IgG4-related fibrous variant of Hashimoto thyroiditis in a non-Asian woman
ea0049gp213
Thyroid hormones deficiencies and poor outcome in chronic heart failure outpatients
ea0049gp214
Hypothyroidism and heart failure outcome: a study with a long-term follow-up
ea0049gp215
The correction of TSH with thyroid replacement therapy is associated with a better outcome in chronic heart failure patients
ea0049gp216
Thyroid 3
Thyroid function in heart failure with preserved ejection fraction (HFpEF) - evaluation of serum and myocardial thyroid hormones in an animal model of HFpEF
ea0049gp217
STAT6 deficiency ameliorates Graves' disease severity by suppressing thyroid epithelial cell hyperplasia
ea0049gp218
Delayed TSH recovery after dose adjustment during TSH-suppressive levothyroxine therapy in patients with differentiated thyroid cancer
ea0049gp219
Analysis of a large cohort of subjects with thyroid hemiagenesis (THA) reveals random seasonality in the dates of birth
ea0049gp220
Thyroid hormone T3 protects mice from fasting induced skeletal muscle atrophy by counteracting autophagy
ea0049gp221
Will it be useful to measure PTH at 4 hours post thyroidectomy to decide for calcium replacement? 1st result of a prospective study
ea0049gp222
Endogenous TH metabolite 3-iodothyronamine (T1AM) and synthetic thyronamine-like analogues SG-1 and SG-2 induce autophagy in human glioblastoma cells (U-87MG)
ea0049gp223
Impact of chronic high fat diet consumption on the expression of organic nutrients carriers in the small intestine of mice: role of thyroid hormones in these processes
ea0049gp224
Thyroid Cancer
Prognostic factors for intrathyroidal papillary carcinomas - a multivariate analysis
ea0049gp225
Malignancy Rate in Thyroid Nodules: Cytology versus Histology in challenging categories
ea0049gp226
Fine needle aspiration biopsy in pediatric patients with thyroid nodules
ea0049gp227
Differentiated thyroid cancer - comparison between patients with and without remission
ea0049gp228
Trends in papillary microcarcinoma prevalence in North of Portugal
ea0049gp229
Radioiodine (RAI) refractory differentiated thyroid cancer (DTC): outcome and prognostic factors for DISEASE progression
ea0049gp230
Management and outcome of bone metastasis from differentiated thyroid carcinoma in the real life: the M.OS.CA.TI. study
ea0049gp231
Germ-line mutations in RET-790 and RET-791 codons (exon 13) among subjects with sporadic medullary thyroid cancer
ea0049gp232
Comparison of clinicopathological features in patients with familial and sporadic papillary thyroid cancer
ea0049gp233
Lobectomy as a treatment option for well differentiated thyroid cancer (WDTC) between 1-4 cm: which results should we expect?
ea0049gp234
Clinical Utility of response to therapy in combination with BRAF in risk assessment of thyroid cancer
ea0049gp235
Thyroid Cancer & Thyroid Case Reports
A rare case of medullary thyroid cancer, mesothelioma and meningioma, due to APC and RASAL1 mutations
ea0049gp236
Thyrotoxic Periodic Paralysis due to Graves' disease: a mandatory differential diagnosis in Asian patients presenting with paralysis and hypokalemia
ea0049gp237
A fatal case of fetal goiter: autoimmunity is the key
ea0049gp238
Renal cell carcinoma metastasis to thyroid tumor: a case report
ea0049gp239
Giant goiter with intrathyroid arteriovenous fistula as a cause of severe pulmonary hypertension
ea0049gp240
Thyroid-related adverse events in patients treated with Nivolumab
ea0049gp241
False negative fine needle aspiration thyroid cytology: an institutional experience
ea0049gp242
Risk factors associated with malignancy in thyroid nodules classified as Bethesda category IV (follicular neoplasm/suspicious for follicular neoplasm)
ea0049gp243
Expressions of miRNAs and BRAFV600E mutation detection in papillary thyroid carcinoma
ea0049gp244
A statistical, in silico model predicts polygenic thyroid cancer risk
ea0049gp245
Eposter Presentations: Adrenal and Neuroendocrine Tumours
Adrenal cortex (to include Cushing's)
Confirmatory tests for diagnosis of primary aldosteronism among Chinese hypertensives
ea0049ep1
The correlation of salivary cortisol values with serum cortisol values
ea0049ep2
Adrenocortical virilizing tumor in an adult woman in remission after surgical therapy performed more than 12 years ago
ea0049ep3
Investigation of atrophic adrenal glands in Cushing's syndrome model rats induced by the administration of dexamethasone
ea0049ep4
Long-term assessment of AddiQoL and patient diaries may identify Addison patients at high risk for adrenal crises
ea0049ep5
Impact of Cortrosyn treatment on weight and adrenal structure in the wistar rat
ea0049ep6
Molecular variability determines subtle adrenal biosynthetic defect in non-classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
ea0049ep7
Corticoids-therapy related complications in patients with primary adrenal insufficiency
ea0049ep8
Severe hypertriglyceridemia in relation to toxic levels of mitotane in a patient with stage IV adrenocortical carcinoma (ACC)
ea0049ep9
Addison's disease presenting as severe hypoglycaemia and cachexia
ea0049ep10
Posterior reversible encephalopathy syndrome (PRES) in a patient with primary aldosteronism
ea0049ep11
Evaluation of cardiovascular risk in patients with adrenal incidentaloma
ea0049ep12
Hair cortisol in patients with primary aldosteronism
ea0049ep13
Salivary steroid levels during diagnostic tests for adrenal insufficiency
ea0049ep14
Assessment of quality of life of patients with Cushing's syndrome depending on the disease course
ea0049ep15
Paraneoplastic Cushing's syndrome and nephrotic syndrome in a patient with bronchial carcinoid
ea0049ep16
Frequancy of diabetes and prediabetes in patients with adrenal incidentaloma without hormonal activity
ea0049ep17
To big to work! Lymphoma presenting with primary adrenal insufficiency
ea0049ep18
Specificity of the posture test for subtyping of primary aldosteronism, a 10 year nationwide summary in Iceland
ea0049ep19
Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells
ea0049ep20
Primary Aldosteronism in Iceland, nationwide results from 2012-2016
ea0049ep21
Cardiovascular risk factors do not play a role in the risk factor profile of adrenal crisis
ea0049ep22
Bilateral adrenal incidentaloma: a diagnostical and therapeutical challenge
ea0049ep23
Are we missing patients with primary aldosteronism (PA) if we require both elevated aldosterone: renin ratio (ARR) and elevated aldosterone levels?
ea0049ep24
Severe hypoglycaemic ketoacidosis in a patient with adrenal crisis
ea0049ep25
Assessment of the hypothalamic pituitary adrenal axis in patients receiving adjuvant mitotane treatment after radical resection of adrenocortical carcinoma
ea0049ep26
Extra-gastrointestinal stromal tumor in the retroperitomeum which had difficulty in differential diagnosis with adrenal cancer
ea0049ep27
Perceptions of medical practitioners' management of addison's disease across Africa: an on-line survey
ea0049ep28
Improved metabolic outcomes for patients with subclinical Cushing's syndrome treated with surgery: Ten year experience in a tertiary centre
ea0049ep29
Severe hypoaldosteronism after unilateral adrenalectomy for primary hyperaldosteronism
ea0049ep30
The role of CYP11B2 polymorphism in the pathogenesis of hypertension in patients with adrenal incidentaloma
ea0049ep31
Primary aldosteronism: more common than once thought: Two clinical cases
ea0049ep32
Rapid reduction in left ventricular mass in primary aldosteronism after treatment; a prospective cardiac MRI study
ea0049ep33
The treatment with dual release hydrocortisone in patients with adrenal insufficiency: correlation between change of the evening cortisol exposure time profile and change in metabolic profile, depression status and quality of life
ea0049ep34
Treatment of adrenal insufficiency with hydrocortisone dual-release formulation: glycometabolic profile and health-related quality of life
ea0049ep35
Transformation from Addison's disease to adrenocortical carcinoma presented as Cushing's syndrome with androgenisation
ea0049ep36
Visinin-Like Protein-1 in the regulation of aldosterone biosynthesis
ea0049ep37
Metabolic syndrome is common among patients with adrenal incidentalomas, but not associated with functional adrenal status
ea0049ep38
The clinical course of patients with adrenal incidentaloma: Başkent University experience
ea0049ep39
Predictive baseline morning P-cortisol levels for the response to a Synacthen test in prednisolone treated patients
ea0049ep40
Silent pheochromocitoma - a rare case of adrenal incidentaloma
ea0049ep41
LH and adrenal tumor size correlate with insulin resistance in menopausal patients with adrenal incidentalomas and (possible) autonomous cortisol secretion
ea0049ep42
A case of recurrent Cushing's disease after total bilateral adrenalectomy
ea0049ep43
Late-night salivary cortisol: cut-off definition and diagnostic value in Cushing's syndrome
ea0049ep44
Adrenal involvement in MEN1 families
ea0049ep45
Differential effects of aldosterone excess on potassium homeostasis and blood pressure in Asian subjects
ea0049ep46
Effect of adrenal mass lateralization on diagnostic tests in patients with Cushing
ea0049ep47
Late night salivary cortisol measurement may help in excluding Cushing's syndrome in patients with chronic kidney disease
ea0049ep48
The short Synacthen test revisited - reevaluation of the normal reference range using LCMSMS
ea0049ep49
Cushing's syndrome in pregnant woman
ea0049ep50
Education sessions in patients with adrenal insufficiency
ea0049ep51
Characteristics of aldosterone-producing adenomas: a tissue microarray study
ea0049ep52
Adrenal cushing's syndrome surprisingly unveiling breast cancer
ea0049ep53
Giant adrenal tumor in a patient admitted for fever
ea0049ep54
The relative risk of developing Addison's disease among patients with type 1 diabetes mellitus: a nationwide, matched, observational cohort study
ea0049ep55
The frequency of incidental liver and renal masses in patients with adrenal incidentalomas
ea0049ep56
Primary adrenal insufficiency: a Portuguese multicentre study by the adrenal tumour study group
ea0049ep57
Adrenal incidentaloma: a challenging dilemma!
ea0049ep58
Assay of steroids with Liquid chromatography tandem mass spectrometry is superior to immunoassays in monitoring patients with 21-hydroxylase deficiency
ea0049ep59
Treatment of patients with primary and secondary adrenal insufficiency with hydrocortisone modified-release (Plenadren®)
ea0049ep60
Autoimmune Addison disease - data from long-term follow-up of patients from a tertiary hospital's Endocrinology Department
ea0049ep61
Effect of GH treatment on coagulation and fibrinolysis parameters in prepubertal children with growth hormone deficiency
ea0049ep62
Treatment with modified-release hydrocortisone for 6 months: A clinical audit in 15 patients with adrenal insufficiency
ea0049ep63
Cushing's Syndrome During Pregnancy mimicking preeclampsia - case report
ea0049ep64
Potentially aggressive adrenal oncocytoma during pregnancy: about one case
ea0049ep65
Primary hyperparathyroidism associated with Cushing syndrome and primary hyperaldosteronism
ea0049ep66
Comparison of biochemical and hormonal parameters in patients with primary adrenal insufficiency of autoimmune and no-autoimmune cause
ea0049ep67
The role of dehydroepiandrosterone sulphate (DHEAS) in the evaluation of autonomous cortisol secretion in adrenal incidentalomas
ea0049ep68
Adrenocortical carcinoma in pregnancy
ea0049ep69
Abnormal aldosterone/renin ratio is common in patients of African compared to European origin, is associated with hypokalaemia, and left ventricular hypertrophy, but is rarely associated with abnormal adrenal imaging characteristics
ea0049ep70
Neutrophil-lymphocyte and platelet-lymphocyte ratios as biomarkers in distinguishing adrenocortical adenomas and carcinomas
ea0049ep71
Adrenal involvement of Non-Hodgkin's lymphoma: a case report
ea0049ep72
Challenges in differential diagnosis of adrenal incidentaloma or clinical case of multiple myeloma
ea0049ep73
Iatrogenic Cushing syndrome and suprarenal secondary insufficiency due to interaction between fluticasone and ritonavir
ea0049ep74
Body composition in women with Cushing's syndrome of different etiology
ea0049ep75
Clinical course of patients with adrenal incidentaloma: retrospective analysis of a single center
ea0049ep76
Malignant androgen-secreting adrenocortical carcinoma with adrenal insufficiency: a case report
ea0049ep77
Hyperaldosteronism screening in Hypertensiologists experience - epidemiological review of over 800 cases
ea0049ep78
Clinical, laboratorial and densitometric evaluation of adult women with congenital adrenal hyperplasia
ea0049ep79
The effect of subclinical hypercortisolism on bone mineral density in female patients with adrenal incidentalomas
ea0049ep80
Long term follow up of patients with adrenal incidentaloma and 'autonomous cortisol secretion'
ea0049ep81
Adrenocortical carcinoma - casuistic analysis
ea0049ep82
A near miss on blaming the heart: a rare case of Adrenocortical carcinoma with thrombus extension into right atrium and Cushing syndrome
ea0049ep83
Congenital Adrenal Hyperplasia due to 11[beta]-Hydroxilase Deficiency: clinical and molecular studies of two novel families with variable phenotypes
ea0049ep84
'Record-breaking hyponatraemia' with Addison's disease
ea0049ep85
24 hour ambulatory blood pressure levels according to adrenal adenoma size
ea0049ep86
Adrenal medulla
Coexisting Graves's disease and pheochromocytoma
ea0049ep87
Pheochromocytoma in neurofibromatosis type 1
ea0049ep88
Should all patients with Neurofibromatosis type 1 undergo biochemical screening for Pheocromocytoma?
ea0049ep89
Pheochromocytoma in pregnancy
ea0049ep90
The role of p27 in pheochromocytoma development
ea0049ep91
Role of microenvironment on metabolic control of murine pheochromocytoma SDHB silenced cells
ea0049ep92
Role of microenvironment on proliferation and migration of an SDHB silenced murine Pheochromocytoma cell line
ea0049ep93
Pheochromocytoma: a clinical and pathological study
ea0049ep94
Biochemical testing for pheochromocytoma
ea0049ep95
Paraganglioma and Fallot Tetralogy: case report
ea0049ep96
Retrospective audit at a UK teaching hospital of phaeochromocytomas and paragangliomas against the 2016 guidelines
ea0049ep97
Pheochromocytoma - surgical outcomes
ea0049ep98
Role of urinary fractionated metanephrines and catecholaminas in the diagnosis of pheochromocytoma/paraganglioma
ea0049ep99
Lung adenocarcinoma in a 34-year-old female SDHB asynptomatic mutation carrier - case report
ea0049ep100
Pheochromositoma in childhood
ea0049ep101
A case of silent pheochromocytoma presenting with clinical and radiological findings suggesting metastatic adrenal lesion
ea0049ep102
The storm before the calm: a phaeochromocytoma
ea0049ep103
Improvement of insulin secretion and oral glucose tolerance after pheochromocytoma removal: a case report
ea0049ep104
Ephedrine/caffeine toxicity masquerading as phaeochromocytoma in a vigorexic male with paroxysmal hypertension and headache
ea0049ep105
Loss diagnosis of pheochromocytoma in the initial evaluation
ea0049ep106
Unexplained resistant hypertension in a young male with recurrent transient ischemic attacks, resembling endocrine hypertension
ea0049ep107
Cardiovascular Endocrinology and Lipid Metabolism
Stress cardiomyopathy in pheochromocytoma
ea0049ep108
Clinical case reports - Pituitary/Adrenal
Prolonged zona glomerulosa insuffiency with hyperkalemia in primary hyperaldosteronism after adrenalectomy
ea0049ep109
Mature ganglioneuroma of the adrenal gland
ea0049ep110
Primary adrenal insufficiency and pregnancy - a case report
ea0049ep111
Paraganglioma (PG) and cyanotic congenital heart disease (CCHD): the role of tisular hypoxia
ea0049ep112
Von Hippel Lindau disease in two Turkish families with different mutations
ea0049ep113
Large adrenal adenoma presenting as a clinically inapparent Cushing syndrome, a trap diagnosis
ea0049ep114
NK/T lymphoma adrenal presenting as adrenal insufficiency and cranial nerves neuropathies-a case report
ea0049ep115
Primary hyperparathyroidism and primary hyperaldosteronism - cause or coincidence in arterial hypertension - case report
ea0049ep116
Endocrine masses displayed as incidentalomas in patients with unilateral nephrectomy
ea0049ep117
Case with metastatic lung cancer who developed adrenal insufficiency
ea0049ep118
Adrenal haemorrhage: from Urology to Endocrinology
ea0049ep119
Hemangioma a rare adrenal tumors: report of two cases
ea0049ep120
A rare case: adrenal lymphangioma
ea0049ep121
A rare case of a patient with MEN 4 phenotype and associated pheochromocytoma
ea0049ep122
The difficulty in predicting aggressive tumour behaviour of phaeochromocytomas
ea0049ep123
An unusual cause of unilateral adrenal haemorrhage
ea0049ep124
Incidentaloma as a first manifestation of lymphoma
ea0049ep125
Clinical case of aldosterone-producing adrenocortical carcinoma
ea0049ep126
The case of adrenal incidentaloma due to unrecognized nonclassic congenital adrenal hyperplasia
ea0049ep127
DOC secreting adrenal adenoma, a rare cause of hypertension
ea0049ep128
Aldosterone-producing adrenocortical carcinoma and alteration of secretion pattern on recurrence: a case report
ea0049ep129
Congenital adrenal hyperplasia: hazards of non-compliance with treatment!
ea0049ep130
Adrenal insufficiency due to both hemorrhage and thrombosis related with primary antiphospholipid syndrome
ea0049ep131
In spite of long-term symptoms, a pheochromocytoma diagnosed in pregnancy results in fetal loss despite proper approach
ea0049ep132
POEMS: a rare cause of adrenal insufficiency in a young male
ea0049ep133
Recurrent phaeochromocytoma - Iatrogenic
ea0049ep134
An association of adrenal ganglioneuroma, Addison's disease and Mediterranean fever: a case report
ea0049ep135
Adrenal carcinoma after ovariectomy. Report of a case
ea0049ep136
ACTH-independent Cushing syndrome with concomitant parathyroid carcinoma
ea0049ep137
Incidental adrenal cyst: a case report
ea0049ep138
Gynecomastia in men: A rare case of adrenal feminizing tumors
ea0049ep139
Virilization - a non-negligible manifestation of an adrenal tumor
ea0049ep140
Clinical case reports - Thyroid/Others
The ovarian origin of hiperandrogenism in the postmenopausal woman with the adrenal adenoma - a case report
ea0049ep141
Secondary autonomic neuropathy in patient with polyglandular autoimmune syndrome III and type 1 gastric neuroendocrine tumor: a case report
ea0049ep142
MEN 1 Syndrome- a case with recurrence of neuroendocrine tumor and hyperparathyroidism after 9 years of follow up
ea0049ep143
Insulinoma- from diagnosis to full recovery. Case study
ea0049ep144
Insulinoma masquerading as neurologic disease
ea0049ep145
Endocrine tumours and neoplasia
Glucose metabolism abnormalities and insulin resistance are frequent in well diferentiated digestive NETs
ea0049ep146
Clinical and hormonal characteristics of adrenal incidentalomas
ea0049ep147
Pituitary insufficiency, the beginning of a diagnostic journey
ea0049ep148
Thyroid carcinoma in multiple endocrine neoplasia type 1
ea0049ep149
Small pancreatic neuroendocrine incidentalomas: an observational prospective study
ea0049ep150
Potential inhibitory effect of progesterone on breast cancer metastasis via the regulation on protein expression of apoptosis- and EMT-related genes
ea0049ep151
Incidental paraganglioma, diagnosis and follow-up - case report
ea0049ep152
Primary hepatic neuroendocrine tumor with multiple liver metastases treated with somatostatin analogues: case report
ea0049ep153
Development of an everolimus-resistant BON1 cell line with altered cell cycle and c-Met activity
ea0049ep154
False positive findings on 6-[18F]fluor-L-3,4-dihydroxyphenylalanine Positron Emission Tomography (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors
ea0049ep155
Imaging follow-up of non-functioning adrenal masses at Vilnius University Hospital Santariskiu Klinikos: 2010-2016
ea0049ep156
Medullary thyroid carcinoma and pheochromocytoma in multiple endocrine neoplasia type 2A - a reversed order diagnosis
ea0049ep157
Bilateral pheochromocytomas, asyptomatic medullary thyroid carcinoma associated with left side thyroid hemiagenesis in a patient with MEN2A: diagnostic correlations
ea0049ep158
Follow-up of adrenal incidentalomas after the initial approach
ea0049ep159
A case of silent pancreatic neuroendocrine tumour of carcinoid variety masquerading as an insulinoma
ea0049ep160
CYP2W1*6 polymorphism as a potential predictive marker of sensitivity to mitotane treatment in adrenocortical carcinoma.
ea0049ep161
Abstract unavailable
ea0049ep162
Ectopic ACTH-syndrome - 31 consecutive patients from the Helsinki University Hospital
ea0049ep163
Ectopic Cushing's syndrome caused by a pulmonary adrenocorticotropic hormone secreting tumour: a case report
ea0049ep164
Could alcohol ablation become the standard of care for benign insulinomas?
ea0049ep165
Clinical characteristics and survival of patients with paraganglioma: a single center experience
ea0049ep166
Corticotroph deficiency in patients with insulinoma
ea0049ep167
Hyperinsulinemic hypoglycemia in a 71-year-old patient with a suspected case of [beta]-cells hyperplasia of pancreatic body and tail- case report
ea0049ep168
Respiratory symtoms lead to a diagnosis of pheochromocytoma: An unusual presentation
ea0049ep169
A rare cause of secondary endocrine hypertension in a young woman with hypokaliemia and recurrent transient ischemic attacks
ea0049ep170
Atypical symptoms of hypoglycemia, hiding a diagnosis of insulinoma: a case report
ea0049ep171
A nomogram consisted of routine biochemical tests may increase the diagnostic accuracy of chromogranin A in detecting patients with neuroendocrine tumors
ea0049ep172
Concentration of dehydroepiandrosterone sulphate in 109 males and 54 females with adrenal tumors
ea0049ep173
Jejunum/ ileum Neuroendocrine Tumours: results of a multicentric retrospective study
ea0049ep174
Follow-up in neuroendocrine tumors: is chromogranin A the confounder?
ea0049ep175
Large intestinal metaplasia is a precancerous lesion present in patients with gastric neuroendocrine neoplasms type 1
ea0049ep176
Pancreatic neuroendocrine tumors (PNETs) in patients with MEN1 syndrome
ea0049ep177
Dysregulation of the components of the splicing machinery in neuroendocrine tumors and its association with malignancy and aggressiveness
ea0049ep178
Serum succinate: investigation of its putative role as a new biomarker in malignant SDH-x mutated pheochromocytoma-paraganglioma patients?
ea0049ep179
Survival analysis of patients with gastroenteropancreatic neuroendocrine tumors
ea0049ep180
Insulinoma - clinical features and outcome of patients diagnosed at a central hospital
ea0049ep181
Effects of ketoconazole on ACTH-producing and non ACTH-producing neuroendocrine tumor cells
ea0049ep182
Treatment with (177Lu)-DOTATATE in patients with advanced metastatic somatostatin receptor-positive tumors
ea0049ep183
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) followed in the endocrinology and nutrition service's monographic outpatient clinics of neuroendocrine tumors in hospital clinico san carlos (HCSC). Description of its characteristics and evolution
ea0049ep184
Descriptive and survival study of 142 cases of gastroenteropancreatic neuroendocrine tumor (GEP-NETs) diagnosed at the Hospital Clinico San Carlos (HCSC)
ea0049ep185
Nonfunctional adrenal incidentaloma affects central blood pressures and arterial stiffness parameters
ea0049ep186
Landscape of sporadic adrenal tumours from surgical unit - histopathological audit of 101 cases from a single centre in Poland
ea0049ep187
An elevated chromogranin A: is it always a tumor progression?-case report
ea0049ep188
An unknown giant neuroendocrine tumor
ea0049ep189
A challenging case of metastatic paraganglioma and metastatic melanoma and prolactinoma
ea0049ep190
Biology and differential diagnosis of calcitonin secreting neuroendocrine tumors
ea0049ep191
Cancerous neuroendocrine vs endocrine tumours: broad commonalities and differences
ea0049ep192
Short-term contralateral recurrence of a Litynski-Conn adenoma
ea0049ep193
Acinic cell adenocarcinoma of the parotid gland associated with paraneoplastic Cushing's syndrome - a rare clinical case
ea0049ep194
Malignant pheochromocytoma - a challenging diagnosis with nonconsensual management
ea0049ep195
Neuroendocrinology
Identification of molecular targets of Sunitinib in pancreatic neuroendocrine tumours
ea0049ep196
Study of different in vitro systems for the evalutation of Sunitinib effects in pancreatic neuroendocrine tumour cells
ea0049ep197
Von Hippel-Lindau syndrome: in vivo portrait with 68Ga-DOTANOC PET-CT
ea0049ep198
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinico-pathological characteristics and disease outcome of 110 patients treated at single referral medical center
ea0049ep199
Insulinoma: diagnostic features and treatment management
ea0049ep200
A rare case: non-islet cell tumor hypoglycemia with adrenal insufficiency
ea0049ep201
Late manifestation of a mixed adenoneuroendocrine carcinoma of the cecum
ea0049ep202
Quality of life in patients with neuroendocrine tumors treated with 177Lu-[DOTA0,Tyr3]-octreotate: a Single Tertiary Care Portuguese Center Experience
ea0049ep203
Triple tumors in a patient with insulinoma
ea0049ep204
Paediatric endocrinology
An analysis of R356W and Q318X mutations and 8 bp deletion in 21-hydroxylase gene CYP21A2 in causing pseudo-precocious puberty in patients with congenital adrenal hyperplasia in Pakistani children
ea0049ep205
Congenital adrenal hyperplasia: impact of therapy on growth and sexual maturation - a 5-year retrospective study of a Tertiary Pediatric Endocrinology Center
ea0049ep206
Pituitary - Clinical
The risk of hypotension, evaluated by ambulatory blood pressure monitoring, during fasting and outside fasting in patients with adrenal insufficiency
ea0049ep207
Steroid metabolism + action
Steroid metabolome changes in the 1 mg dexamethasone suppression test
ea0049ep208
Thyroid cancer
Clinical relevance of RET proto-oncogene variants L769L and S836S (exon 11, 13, 14, and 15) in patients with sporadic medullary thyroid carcinoma
ea0049ep209
Eposter Presentations: Calcium and Bone
Bone & Osteoporosis
Abstract unavailable
ea0049ep210
Bisphosphonate related osteonecrosis of the jaw: risk factors: a case report
ea0049ep211
Salmon calcitonin affects thyroid endocrine cells and trabecular bone in a rat model of male osteoporosis
ea0049ep212
Primary hyperparathyroidism: hormonal profile and risk of complications
ea0049ep213
Efficacy and safety of bisphosphonate discontinuation in postmenopausal osteoporosis: a systematic review
ea0049ep214
Osteopetrosis vs Osteogenesis Imperfecta-is that so hard to distinquish? Case report
ea0049ep215
Osteonecrosis of the jaw and bilateral atypical femoral fracture both occurring during treatment of osteoporosis
ea0049ep216
Clinical manifestations and treatment approach in osteogenesis imperfecta
ea0049ep217
Special features of body composition and bone mineral metabolism in children with primary nephrotic syndrome
ea0049ep218
Bone densitometry of type 2 diabetics (about 290 patients)
ea0049ep219
Effects of acromegaly on bone tissue mRNA levels relevant to bone metabolism
ea0049ep220
Osteoporosis and fractures in the real world setting
ea0049ep221
Is osteoporosis a curable disease?
ea0049ep222
Fractures at post-partum and lactation: common presentation of different clinical entities
ea0049ep223
A multidisciplinary clinic for bone metabolism diseases; descriptive analysis of our experience in quiron salud malaga hospital
ea0049ep224
Spontaneous recovery of BMD after surgical cure of Cushing's syndrome due to an adrenocortical adenoma: a 9-years follow-up
ea0049ep225
Cinacalcet for control of primary hyperparathyroidism: a single centre experience
ea0049ep226
Bone remodeling markers predict bone loss in premenopausal women
ea0049ep227
Bone mineral density in hospital male physicians over the age of 65
ea0049ep228
Association between bone mineral density and muscle strength in patients with Turner syndrome, after consideration of selected hormonal and metabolic parameters
ea0049ep229
Volumes of visceral adipose tissue, gynoid and android fat as predictors of reduced bone mineral density in women with menstrual disorders
ea0049ep230
Effect of chronic atrophic gastritis on bone mineral density of Korean women
ea0049ep231
May serotonin metabolism polymorphisms 5HTTVNTR and 5HT
2A
have a clinical impact in osteoporosis development?
ea0049ep232
The effect of mechanical assisted squat exercise on pulmonary function, muscle mass and function with or without sarcopenia
ea0049ep233
Beta-2 adrenergic receptor (ADRB2) gene polymorphism Arg16Gly as risk factor for osteoporosis
ea0049ep234
Bone histomorphometry and bone marrow adipocytes in premenopausal women with type 2 diabetes
ea0049ep235
Differences in bone strength and metabolic parameters according to the presence of hyperadiponectinemia and obesity in Korean adults: The KoGES- ARIRANG study
ea0049ep236
Do the surgical outcomes change if the surgeon accompanies the endocrinologist during the preoperative ultrasonography examination?
ea0049ep237
Teriparatide discontinuation in a patient with post surgical hypoparathyroidism: a clinical challenge
ea0049ep238
Endocrine disorders in treatment-naive male patients with HIV infection
ea0049ep239
Trabecular bone score is negatively associated with bone resorbtion markers in patients with primary hyperparathyroidism
ea0049ep240
Normocalcemic primary hyperparathyroidism (NPH)
ea0049ep241
Secondary hyperparathyroidism and its implication on bone mineral density in patients with different stages of chronic kidney disease
ea0049ep242
Impact of vitamin D on the bone quality assessed by trabecular bone score in men
ea0049ep243
Neutrophil lymphocyte ratio in 6 month teriparatide therapy of osteoporosis
ea0049ep244
Analysis of DXA scans of males performed in clinical center of vojvodina
ea0049ep245
Biological assessment and causes of secondary osteoporosis
ea0049ep246
Calcium & Vitamin D metabolism
Management with Cinacalcet of non-surgical primary hyperparathyroidism in the elderly.
ea0049ep247
Glucocorticoids regulate expression of lung calbindin-D9k in mouse
ea0049ep248
Vitamin D intoxication caused hypercalcemia: Case report
ea0049ep249
Abstract unavailable
ea0049ep250
Gitelman syndrome and primary hyperparathyroidism - a rare association
ea0049ep251
The volume of parathyroid adenoma is related to presurgical PTH and 25OH-D3, but not calcium levels at patients with primary hyperparathyroidism
ea0049ep252
Pseudohypoparathyroidism type Ib: a case of chronic severe hypocalcaemia and seizures diagnosed in adulthood
ea0049ep253
A practice review of the use of cinacalcet in primary hyperparathyroidism
ea0049ep254
Is there a threshold of Vitamin D sufficiency that can prevent secondary hyperparathyroidism?
ea0049ep255
Spontaneous remission of parathyroid adenoma due to parathyroid apoplexy: a case report
ea0049ep256
Normocalcemic versus Hypercalcemic Primary Hyperparathyroidism: a comparative study
ea0049ep257
Parathyroid carcinoma: experience of a Portuguese centre
ea0049ep258
Vitamin D prescribing bias in liver transplant referrals
ea0049ep259
How to differentiate primary hyperparathyroidism with D hypovitaminosis from secondary hyperparathyroidism due to D hypovitaminosis?
ea0049ep260
Pseudohypoparathyroidism as an etiological cause for epilepsy: a case report
ea0049ep261
Long standing primary hyperparathyroidism consequences after parathyroid surgery: fast recovery not only for bone mass
ea0049ep262
Associations of nitric oxide with vitamin D and other serological factors in healthy adolescents
ea0049ep263
Primary hyperparathyroidism in pregnancy
ea0049ep264
Eucalcemic parathyroid hormone elevation after parathyroid surgery for sporadic primary hyperparathyroidism
ea0049ep265
Primary hyperparathyroidism mimicking metastatic bone disease
ea0049ep266
Acute pancreatitis as the first presentation of primary hyperparathyroidism
ea0049ep267
Gender difference in clinical presentation of primary hyperparathyroidism
ea0049ep268
Prevalence of hypocalcemia in adults in Minsk, Belarus
ea0049ep269
Assessment of changing in the therapeutic attitude in patients with primary hyperparathyrodism in conservative management after the realization of radial densitometry
ea0049ep270
A rare case: intrathymic parathyroid adenoma
ea0049ep271
Audit of emergency hypercalcaemia management in the acute medical unit
ea0049ep272
Higher circulating parathyroid hormone concentration fascilitates preoperative diagnostic imagings for localization in primary hyperparathyroidism
ea0049ep273
Calcifediol is more effective than cholecalciferol in the treatment of severe vitamin D deficiency in a patient submitted to malabsorbitive bariatric surgery: a case report
ea0049ep274
The effect of 1,25(OH)2D3 on interferon i secretion by human mononuclear cells in vitro
ea0049ep275
The changing face of primary hyperparathyroidism
ea0049ep276
Single center experience of intact parathyroid hormone determination in washout samples of suspicious parathyroid adenomas
ea0049ep277
Primary hyperparathyroidism due to atypical adenoma: clinical, biochemical and histological features of an Italian cohort
ea0049ep278
Medullary vertebral compression in primary hyperparathyroidism
ea0049ep279
Management of primary hyperparathyroidism: Experience of a large UK teaching hospital
ea0049ep280
Fahr Syndrome and idiopathic primary hipoparathyroidism - clinical case
ea0049ep281
Clinical presentations of four patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumor syndrome
ea0049ep282
When is it worthwhile to perform parathyroid SPECT/CT scintigraphy in primary hyperparathyroidism?
ea0049ep283
Parathormone (PTH) as a marker of vitamin D (VitD) deficiency
ea0049ep284
Pathological basal ganglia calcification in isolated idiopathic hypoparathyroidism: a case report
ea0049ep285
Diseases associated with hypercalcemia
ea0049ep286
PTH levels in vitamin D deficiency
ea0049ep287
Renal complications in patients with chronic postoperative hypoparathyroidism treated with oral calcium and active vitamin D metabolites
ea0049ep288
The results of parathormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas for focused parathyroidectomy in patients with negative or suspicious sestamibi scans
ea0049ep289
Weight has a weak influence on calcium-phosphorus metabolism in HIV-patients with vitamin d deficiency
ea0049ep290
Chronic hypoparathyroidism disease profile from 492 patients in the PARADIGHM natural history global registry
ea0049ep291
Prevalence of cardiometabolic risk factors among Saudi Women with vitamin D deficiency
ea0049ep292
18F-choline PET/MRI in patients with primary hyperparathyroidism and negative sestamibi SPECT/CT - report of two cases
ea0049ep293
Severe hypocalcemia induced by Denosumab in a patient with Osteroporosis after malabsorptive bariatric surgery
ea0049ep294
Performance characteristics of a new Waters MassTrak Vitamin D assay
ea0049ep295
Vitamin D intoxication complicated with parathormon treatment in elderly: a case report
ea0049ep296
Tc-99m sestamibi uptake by brown tumours
in a patient with primary hyperparathyroidism
ea0049ep297
Thyroid supression in patients with primary hyperparathyroidism may improve pre-surgical scintigraphy localisation
ea0049ep298
Serum vitamin D in overweight patients with normal and impaired GFR
ea0049ep299
The importance of ultrasound in the preoperative evaluation of patients with primary hyperthyroidism: a case report
ea0049ep300
Abstract unavailable
ea0049ep301
Ectopic production of calcitriol by non-hodgkin lymphoma as a cause of hypercalcemia: case report
ea0049ep302
Primary hyperparathyroidism: elective parathyroidectomy versus conservative management; results of a retrospective cohort study
ea0049ep303
Calcium metabolism and autoimmune thyroiditis
ea0049ep304
Pseudohypoparathyroidism (PHP) and GNAS gene mutations - clinical spectrum from PHP type 1a to pseudopseudohypoparathyroidism
ea0049ep305
Hyperparathyroidism and cardiovascular risk
ea0049ep306
Risk factors associated with osteoporosis in beta-thalassaemia major patients
ea0049ep307
Giants walk amongst us
ea0049ep308
Hungry bone syndrome after treatment of severe primary hyperparathyroidism
ea0049ep309
Clinical review of nine cases of pseudohypoparathyroidism
ea0049ep310
Severe hypercalcemia revealing an atypical parathyroid adenoma
ea0049ep311
Cardiovascular Endocrinology and Lipid Metabolism
Hypercalcemia and cardiovascular disease
ea0049ep312
Vitamin D levels in obese adults and cardiovascular risk
ea0049ep313
Clinical case reports - Pituitary/Adrenal
Partial gigantism: case report
ea0049ep314
Clinical case reports - Thyroid/Others
An unique case of celiac disease with hypocoagulation and secondary hyperparathyreodism in elderly patient - a case report
ea0049ep315
Optic neuritis as presenting complaint in primary hypoparathyroidism
ea0049ep316
The parathyroid carcinoma in a young adult male
ea0049ep317
Clinical case of atypical parathyroid adenoma with severe hypercalcemia and multiple fragility fractures
ea0049ep318
Congenital fibrous dysplasia and Klinefelter syndrome: coincidence or not?
ea0049ep319
Parathyroid nodular hyperplasia: when imaging exams fail
ea0049ep320
As clear as mud: an atypical case of primary hyperparathyroidism
ea0049ep321
Familial hypocalciuric hypercalcemia with a new heterozygous missense mutation of CaSR gene and cinacalcet treatment
ea0049ep322
Parathyroid carcinoma can be misdiagnosis with medullary thyroid cancer: how is that possible?
ea0049ep323
Clinical case of pachydermoperiostosis
ea0049ep324
Vascular dementia in a 57-year old woman with adenoma of parathyroid gland
ea0049ep325
Equivocal preoperative imaging including 18F-fluorocholine PET-CT in primary hyperparathyroidism and nodular thyroid disease - case report
ea0049ep326
Parathyroid carcinoma: a report of cases
ea0049ep327
A rare case of giant parathyroid adenoma: diagnostic and therapeutic aspects
ea0049ep328
Autosomal dominant hypocalcemia in a Portuguese family: novel mutation in the calcium-sensing receptor gene
ea0049ep329
A case of intrathyroidal parathyroid adenoma presented with severe 25(OH)D3 deficiency, bone pain and high PTH
ea0049ep330
The rare cause of primary hyperparathyroidism: Parathyroid Carcinoma
ea0049ep331
A parathyroid adenoma presented with diffuse bone lesions and anemia
ea0049ep332
Common bone lesions may be a sign of parathyroid carcinoma in the primary hyperparathyroidism
ea0049ep333
Broken bones and blindness- a rare cause of osteoporosis
ea0049ep334
An usual cause of post operative hypocalcemia
ea0049ep335
Brown tumor in a normocalcemic patient
ea0049ep336
Symptomatic bisphosphonate-induced hypocalcaemia after severe idiopathic hypercalcaemia
ea0049ep337
Transient hyperglycemia during the course of primary hypoparathyroidism: Case study
ea0049ep338
Hyperparathyroidism jaw tumour syndrome (HPT-JT)
ea0049ep339
Fahr syndrome revealing a pseudohypoparathyroidism
ea0049ep340
Parathyroid cyst: the forgotten diagnosis of a neck mass
ea0049ep341
[ldquo]Pseudo or not[rdquo]: differential diagnosis of hyperparathyroidism with severe electrolyte imbalance in transgender patient: a challenging case report
ea0049ep342
Developmental endocrinology
Adolescent onset distal renal tubular acidosis presenting with significant growth retardation without rickets
ea0049ep343
Endocrine tumours and neoplasia
Differential roles of carboxylated and uncarboxylated Osteocalcin in stage I breast cancer as a diagnostic biomarker
ea0049ep344
Gross CDC73 deletions in young patients with primary hyperparathyroidism in Russia
ea0049ep345
Multiple endocrine neoplasia type 1 phenocopies: role of the genes associated with familial primary hyperparathyroidism
ea0049ep346
Recurrent ectopic parathyroid carcinoma
ea0049ep347
Exome analysis of a large family with familial isolated primary hyperparathyroidism (FIHP) and multiple cancers
ea0049ep348
Parathyroid cancer - clinical presentation, prognostic factors and long-term evolution
ea0049ep349
A suspicious case of multiple endocrine neoplasia
ea0049ep350
Endocrine tumours and neoplasia (1)
Bone mineral density in obese children
ea0049ep351
Paediatric endocrinology
Progressive osseous heteroplasia in a child with pseudohypoparathyroidism type I
ea0049ep352
Steroid metabolism + action
Genetic variations in the HSD11B1 gene in patients treated with glucocorticoids show associations with bone mineral density
ea0049ep353
Eposter Presentations: Diabetes, Obesity and Metabolism
Calcium & Vitamin D metabolism
Abstract unavailable
ea0049ep354
Cardiovascular Endocrinology and Lipid Metabolism
Metabolic syndrome in digestive neoplasms
ea0049ep355
Dyslipidemia-associated skin lesions as a short key for etiology unraveling and management of life-threatening acute pancreatitis in young male
ea0049ep356
Metformin and changes in blood pressure and heart rate in lean patients with polycystic ovary syndrome (PCOS)- preliminary study
ea0049ep357
Screening for type 2 diabetes mellitus as a method of secondary prevention of cardiovascular lesions
ea0049ep358
Soybean phytoestrogens reduce 27-hydroxycholesterol concentration in the liver of middle-aged female rats
ea0049ep359
Awareness and prevalence of metabolic syndrome among high-risk individuals attending internal medicine clinics across Jordan
ea0049ep360
Nine months of practice in California - self-referrals in endocrinology
ea0049ep361
Identifiying underdiagnosed or undertreated patients with familial hypercholesterolemia from the central laboratory registries
ea0049ep362
The effect of admission hyperglycemia on clinical outcome of ischaemic stroke patients
ea0049ep363
Deleting genomic region of Hsd17b1 in mice results into a hypomorphic Naglu allele, and consequently to a phenotype mimicking a lysosomal storage disease
ea0049ep364
Salivary lactate levels during anaerobic threshold (AT) training
ea0049ep365
The effect of tocilizumab - an interleukin-6 receptor antagonist - on lipid levels in rheumatoid arthritis
ea0049ep366
Homocystein-significant marker of metabolic syndrome and atherosclerosis risk
ea0049ep367
Graft vs host disease and insulin resistance after bone marrow transplantation
ea0049ep368
Coronary artery calcium score in prediabetes - preliminary results
ea0049ep369
Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance
ea0049ep370
Metformin and changes in serum lipid profile in lean patients with polycystic ovary syndrome (PCOS)
ea0049ep371
Prevalence of major cardiovascular risk factors among people living with HIV in a low risk country for cardiovascular disease
ea0049ep372
The role of leptin signalling in the development of cardiovascular diseases in obesity
ea0049ep373
Influence factors on lipid profile among patients with rheumatoid arthritis
ea0049ep374
Abstract unavailable
ea0049ep375
Oxidative stress and metabolic profiles assessment after melatonin and irbesartan co-administration in a novel pharmaceutical formulation
ea0049ep376
The dual FXR/TGR5 agonist INT-767 counteracts nonalcoholic steatohepatitis and visceral adipose tissue dysfunction in a rabbit model of high fat diet-induced metabolic syndrome
ea0049ep377
Prevalence of metabolic syndrome and its relation to physical activity and nutrition in Azerbaijan
ea0049ep378
Isolated low HDL-Cholesterol in patients with type 2 diabetes about 168 cases
ea0049ep379
Can hypoglycemic episodes in type 1 diabetics trigger cardiac arrhythmias?
ea0049ep380
Family hypercholesterolemia: about 4 cases
ea0049ep381
Description of an educational intervention lifestyle program in reducing cardiovascular risk factors
ea0049ep382
Role of lactate dehydrogenase-A (LDH-A) in atherosclerosis
ea0049ep383
Clinical case reports - Pituitary/Adrenal
Prediction of type 1 diabetes in autoimmune polyglandular syndrome type 2
ea0049ep384
Clinical case reports - Thyroid/Others
Insulin autoimmune syndrome (Hirata Disease) triggered by a tyrosine kinase inhibitor drug in a Latin American patient
ea0049ep385
Fulminant diabetic ketoacidosis complicating nivolumab immunotherapy
ea0049ep386